Company news
Harrow, Inc. news in 2021
Harrow, Inc.'s news releases, calls and decks from 2021, newest first.
Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
December 19, 2021
Harrow Health Added to the Nasdaq Biotechnology Index
December 12, 2021
EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce Expanded U.S. Commercial Alliance for DEXYCU®
December 6, 2021
Harrow Health Announces Third Quarter 2021 Financial Results
November 8, 2021
Harrow Health to Announce Third Quarter 2021 Financial Results on November 9, 2021
October 24, 2021
Harrow Health Provides $13.5 Million Senior Secured Loan to Melt Pharmaceuticals
September 1, 2021
Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.
August 17, 2021
Harrow Health to Participate in Two Upcoming Virtual Investor Conferences
August 11, 2021
Harrow Health Announces Second Quarter 2021 Financial Results
August 9, 2021
Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica
July 26, 2021
Harrow Health to Announce Second Quarter 2021 Financial Results on August 10, 2021
July 25, 2021
NovaBay Pharmaceuticals Partners with Harrow Health’s ImprimisRx® to Promote Prescription Avenova
July 18, 2021
Harrow Health Granted Two Patents for Novel Surgical Dilation Formulation
July 14, 2021
Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
June 16, 2021
Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
June 13, 2021
Harrow Health Announces Offering of $17.5 Million of 8.625% Senior Notes Due 2026 and “BB” Rating from Egan-Jones
June 13, 2021
Visionology Acquires Exclusive Worldwide License to SPARCS Contrast Sensitivity Testing Technology
June 2, 2021
Harrow Health Launches New Corporate and Investor Website
May 31, 2021
Leading Peer-Reviewed Ophthalmic Journal Publishes Study on ImprimisRx’s Proprietary Klarity-C® Drops
May 16, 2021
Harrow Health Announces Record First Quarter 2021 Financial Results
May 10, 2021
Harrow Health Raises Approximately $11 Million in Sale of Series B Preferred Stock
May 4, 2021
Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes
May 4, 2021
Harrow Health to Announce First Quarter 2021 Financial Results on May 11, 2021
April 26, 2021
Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026
April 19, 2021
Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
April 14, 2021
Harrow Health Announces Preliminary First Quarter 2021 Financial Results
April 13, 2021
Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones
April 13, 2021
Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results
March 7, 2021
Harrow Health to Participate in H.C. Wainwright Global Life Sciences Conference
March 1, 2021
Harrow Health to Announce Fourth Quarter and Year-End 2020 Financial Results on March 8, 2021
February 24, 2021
Calls in 2021
Decks in 2021
- Harrow Health — Investor Presentation (August 2021)
Investor deck · 15 slides · August 2021
- Harrow Health — Investor Presentation (March 2021)
Investor deck · 15 slides · Mar 8, 2021